|
2024
|
Invention
|
Compositions of grapiprant and methods for using the same.
The present disclosure provides a met... |
|
|
Invention
|
Eye drop composition.
The present invention relates to an eye-drop composition comprising 2-amin... |
|
2021
|
Invention
|
Compositions of grapiprant and methods for using the same. The present disclosure provides a meth... |
|
|
Invention
|
Eye drop composition. The present invention relates to an eye-drop composition comprising 2-amino... |
|
2017
|
Invention
|
Compositions and methods for chronic use of a weight-gaining compound. Provided herein is a metho... |
|
2016
|
Invention
|
Monoclonal antibodies directed to cd20.
The invention provides antibody to canine or feline or e... |
|
2015
|
Invention
|
Crystalline forms of grapiprant. The present disclosure provides a crystalline form of grapiprant... |
|
|
Invention
|
Crystalline forms of grapiprant.
The present disclosure provides a crystalline form of... |
|
2014
|
Invention
|
Monoclonal antibodies directed to cd52.
The invention provides antibody to canine or feline or e... |
|
2013
|
Invention
|
Compositions and methods of use of an inappetance-controlling compound. The invention provides fo... |
|
|
Invention
|
Antibody constant domain regions and uses thereof.
The invention provides recombinant protein (e... |
|
|
Invention
|
Monoclonal antibodies.
The invention provides heterochimeric antibodies and/or fragments thereof... |
|
2011
|
Invention
|
Method for preparing cyclopropane derivatives. The present invention relates to the preparation o... |
|
|
Invention
|
Method for preparing cyclopropane derivatives. The present invention relates to the prepara... |
|
|
Invention
|
Monoclonal antibodies directed to cd20. The invention provides antibody to canine or feline or eq... |
|
|
Invention
|
Monoclonal antibodies directed to cd52. The invention provides antibody to canine or feline or eq... |
|
2010
|
Invention
|
Antibody constant domain regions and uses thereof. The invention provides recombinant protein (e.... |
|
2009
|
Invention
|
Monoclonal antibodies. The invention provides heterochimeric antibodies and/or fragments thereof ... |
